62 related articles for article (PubMed ID: 6095566)
1. Further studies on the biochemical characterization of the MC-29 virus derived transplantable hepatoma (VTH). II. Modification of cyclic adenosine-3',5'-monophosphate levels by catecholamines, glucagon and Vinca alkaloids in normal chicken liver and VTH.
Gyapay G; Lapis E; Jeney A; Lapis K
Acta Biol Hung; 1984; 35(1):35-41. PubMed ID: 6095566
[TBL] [Abstract][Full Text] [Related]
2. Further studies on the biochemical characterization of the MC-29 virus derived transplantable hepatoma (VTH). I. Binding of 3H-cortisol to cytoplasmic receptor and DNA.
Kovalszky I; Jeney A; Lapis K; Bencsáth M
Acta Biol Hung; 1984; 35(1):27-34. PubMed ID: 6239473
[TBL] [Abstract][Full Text] [Related]
3. The regulation of cyclic AMP levels in cultured MH1C1 rat hepatoma cells and in solid tumours derived from MH1C1 cell inoculates.
Brønstad GO; Gladhaug IP; Haffner F; Rugstad HE; Christoffersen T
Anticancer Res; 1987; 7(2):155-60. PubMed ID: 3035996
[TBL] [Abstract][Full Text] [Related]
4. Chromatin alterations and gene function disorder in MC-29 virus-derived hepatoma.
Jeney A; Kovalszky I; Gyapay G; Lapis K; Suba Z
J Toxicol Environ Health; 1979; 5(2-3):509-16. PubMed ID: 224207
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate action.
Christ B; Nath A; Jungermann K
Hepatology; 1997 Jul; 26(1):73-80. PubMed ID: 9214454
[TBL] [Abstract][Full Text] [Related]
6. Anomalous adenosine cyclic 3':5'-monophosphate responses to glucagon in patients with hepatocellular carcinoma.
Pun KK; Ho PW; Yeung RT
Cancer Res; 1986 Apr; 46(4 Pt 2):2152-4. PubMed ID: 3004721
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucagon on amino acid transport and cyclic adenosine 3':5'-monophosphate production in rat hepatoma cell line McA-RH 8994 in culture.
Kelley DS
Cancer Res; 1982 Aug; 42(8):3116-9. PubMed ID: 6284359
[No Abstract] [Full Text] [Related]
8. Mechanisms of hormonal regulation of liver metabolism.
Exton JH; Blackmore PF; El-Refai MF; Dehaye JP; Strickland WG; Cherrington AD; Chan TM; Assimacopoulos-Jeannet FD; Chrisman TD
Adv Cyclic Nucleotide Res; 1981; 14():491-505. PubMed ID: 6116389
[TBL] [Abstract][Full Text] [Related]
9. Regulation of urea cycle enzymes in transplantable hepatomas and in the livers of tumor-bearing rats and humans.
Brebnor LD; Grimm J; Balinsky JB
Cancer Res; 1981 Jul; 41(7):2692-9. PubMed ID: 6265064
[TBL] [Abstract][Full Text] [Related]
10. The role of catecholamines and glucagon on serum and liver metallothionein response to restraint stress.
Hidalgo J; Garvey JS; Armario A
Rev Esp Fisiol; 1987 Dec; 43(4):433-7. PubMed ID: 3448709
[TBL] [Abstract][Full Text] [Related]
11. Hepatic insensitivity to glucagon in ob/ob mice.
Yen TT; Stamm NB; Fuller RW; Root MA
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):29-40. PubMed ID: 6254120
[TBL] [Abstract][Full Text] [Related]
12. Biochemical behavior of MC-29 virus-induced transplantable chicken hepatoma.
Prajda N; Eckhardt S; Suba Z; Lapis K
J Toxicol Environ Health; 1979; 5(2-3):503-8. PubMed ID: 224206
[TBL] [Abstract][Full Text] [Related]
13. Ontogeny of glucagon and isoproterenol induced cyclic 3'-5' adenosine monophosphate production in adipocytes isolated from the inguinal adipose tissue of developing rats.
Gaben AM; Jahchan T; Swierczewski W; Rosselin G
J Dev Physiol; 1982 Feb; 4(1):75-83. PubMed ID: 6179979
[TBL] [Abstract][Full Text] [Related]
14. The pancreatohepatorenal cAMP-adenosine mechanism.
Jackson EK; Mi Z; Zacharia LC; Tofovic SP; Dubey RK
J Pharmacol Exp Ther; 2007 May; 321(2):799-809. PubMed ID: 17314200
[TBL] [Abstract][Full Text] [Related]
15. Increase of cyclic adenosine 3':5'-monophosphate concentration in transplantable lymphoma cells by vinca alkaloids.
Kotani M; Koizumi Y; Yamada T; Kawasaki A; Akabane T
Cancer Res; 1978 Sep; 38(9):3094-9. PubMed ID: 209896
[No Abstract] [Full Text] [Related]
16. [Insulin and glucagon receptors in the liver. Their regulation].
Broer Y
Med Chir Dig; 1981; 10(8):669-71. PubMed ID: 6279980
[No Abstract] [Full Text] [Related]
17. PGE1-independent MDCK cells have elevated intracellular cyclic AMP but retain the growth stimulatory effects of glucagon and epidermal growth factor in serum-free medium.
Taub M; Devis PE; Grohol SH
J Cell Physiol; 1984 Jul; 120(1):19-28. PubMed ID: 6203919
[TBL] [Abstract][Full Text] [Related]
18. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
[TBL] [Abstract][Full Text] [Related]
19. Bacterial toxins and glucagon in liver cAMP regulation: a physiopathological role in liver diseases?
Scevola D; Barbarini G; Marone P; Casciarri I; Bernardi R; Magliulo E
Boll Ist Sieroter Milan; 1980; 59(6):655-61. PubMed ID: 6263294
[TBL] [Abstract][Full Text] [Related]
20. Differences in dihydroergotamine antagonism of glucose release by catecholamines, glucagon and adenosine 3',5'-monophosphate in rabbit liver slices.
Chan PS; Ellis S; Mühlbachová E
Br J Pharmacol; 1978 Aug; 63(4):593-7. PubMed ID: 210874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
